Protein dynamics at invadopodia control invasion-migration transitions in melanoma cells.
Fiche publication
Date publication
mars 2023
Journal
Cell death & disease
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DUJARDIN Denis, Dr RONDE Philippe, Pr GIES Jean-Pierre, Dr SICK Emilie
Tous les auteurs :
Legrand M, Mousson A, Carl P, Rossé L, Justiniano H, Gies JP, Bouvard D, Sick E, Dujardin D, Rondé P
Lien Pubmed
Résumé
Cell invasion is a highly complex process that requires the coordination of cell migration and degradation of the extracellular matrix. In melanoma cells, as in many highly invasive cancer cell types these processes are driven by the regulated formation of adhesives structures such as focal adhesions and invasive structures like invadopodia. Structurally, focal adhesion and invadopodia are quite distinct, yet they share many protein constituents. However, quantitative understanding of the interaction of invadopodia with focal adhesion is lacking, and how invadopodia turn-over is associated with invasion-migration transition cycles remains unknown. In this study, we investigated the role of Pyk2, cortactin and Tks5 in invadopodia turnover and their relation with focal adhesions. We found that active Pyk2 and cortactin are localised at both focal adhesions and invadopodia. At invadopodia, localisation of active Pyk2 is correlated with ECM degradation. During invadopodia disassembly, Pyk2 and cortactin but not Tks5 are often relocated at nearby nascent adhesions. We also show that during ECM degradation, cell migration is reduced which is likely related to the sharing of common molecules within the two structures. Finally, we found that the dual FAK/Pyk2 inhibitor PF-431396 inhibits both focal adhesion and invadopodia activities thereby reducing both migration and ECM degradation.
Référence
Cell Death Dis. 2023 03 11;14(3):190